Masakazu Takagi

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial

Wasaburo Koizumi, Hiroyuki Narahara, Takuo Hara et al. · The Lancet Oncology · 2008 · 1.9K citations

Medicine, Oncology, Chemotherapy +7

Short-term surgical outcomes from a phase III study of laparoscopy-assisted versus open distal gastrectomy with nodal dissection for clinical stage IA/IB gastric cancer: Japan Clinical Oncology Group Study JCOG0912

Hitoshi Katai, Junki Mizusawa, Hiroshi Katayama et al. · Gastric Cancer · 2016 · 391 citations · Full text

Medicine, Oncology, Surgery +16

Survival outcomes after laparoscopy-assisted distal gastrectomy versus open distal gastrectomy with nodal dissection for clinical stage IA or IB gastric cancer (JCOG0912): a multicentre, non-inferiority, phase 3 randomised controlled trial

Hitoshi Katai, Junki Mizusawa, Hiroshi Katayama et al. · ˜The œLancet. Gastroenterology & hepatology · 2019 · 320 citations

Medicine, Oncology, Surgery +15

Gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer (JCOG0501): an open-label, phase 3, randomized controlled trial

Yoshiaki Iwasaki, Masanori Terashima, Junki Mizusawa et al. · Gastric Cancer · 2020 · 170 citations · Full text

Medicine, Oncology, Surgery +12

A Phase III Study of Laparoscopy-assisted Versus Open Distal Gastrectomy with Nodal Dissection for Clinical Stage IA/IB Gastric Cancer (JCOG0912)

Kenichi Nakamura, Hitoshi Katai, Junki Mizusawa et al. · Japanese Journal of Clinical Oncology · 2012 · 152 citations · Full text

Medicine, Oncology, Surgery +17